“I believe that all treatment should be designed collaboratively by the doctor and the patient, and that each patient should receive all of the treatment they need, without any treatment they do not need.”
What was your path to becoming a therapist?
I was born and raised in New York. I received my Bachelors degree from Cornell University and attended medical school at NYU. I completed psychiatry residency training and fellowships at Mount Sinai School of Medicine, where I currently serve as an assistant professor in the Department of Psychiatry.
What would you want someone to know about working with you?
As a physician, I focus on completely individualized treatment that fits the client in front of me. While I offer a full range of psychiatric services, I see some clients exclusively for talk therapy and others who are receiving IV ketamine infusions and Transcranial Magnetic Stimulation. I believe that all treatment should be designed collaboratively by the doctor and the patient, and that each patient should receive all of the treatment they need, without any treatment they do not need.
What’s your area of focus?
I primarily treat adults and adolescents needing psychiatric care for illnesses including depression, bipolar disorder, anxiety, adult and adolescent ADHD, substance use, eating disorders, and reproductive issues like PMADs (perinatal mood and anxiety disorders). I provide treatment using a range of modalities, from psychotherapy without medication to psychopharmacology (medication management), to the most advanced interventional treatment options, such as IV ketamine infusions and TMS, a non-invasive, non-medication treatment for depression, OCD, and anxiety. Over the last decade, I have established myself as an educational voice for ketamine therapy and other innovative psychiatric illness treatment options. I write and speak regularly on innovation in psychiatry and have published over 100 articles covering topics like advancement in ketamine therapy, depression, and anxiety.
What excites you most about the evolving mental health landscape?
The evolution of advanced interventional options for psychiatric treatment, including enhanced Deep Transcranial Magnetic Stimulation (dTMS), brexanolone for postpartum depression, and Ketamine-Assisted Psychotherapy, means that there are finally new treatments for those who have suffered without relief in the past. Similar such treatments are in the pipeline and we’re looking forward to having new tools to help patients manage their darkest times, especially when other treatments have been inadequate for them. We're becoming better equipped to save lives and allow patients to survive and go on to deepen their work in psychotherapy and recover.
How does collaboration with other providers play into your work?
Collaboration with other providers is a natural and important element of care for individuals in any form of psychotherapy. Collaboration results in additional valuable insight that allows providers to better articulate the broad factors influencing a patient’s condition and tailor their care with greater nuance and clarity. Collaboration also allows me to learn from my peers, which is an added bonus.
“The evolution of advanced interventional options for psychiatric treatment means that there are finally new treatments for those who have suffered without relief in the past.”